|Articles|July 1, 2004

July 2004 - Part 1
Volume 10
Issue 7 Pt 1

Cost Impacts of Illness on Families and Society

Author(s)David Share, MD, MPH

Download PDF: Cost Impacts of Illness on Families and Society

Articles in this issue

about 22 years ago

Article

Potential Application of the National Kidney Foundation's Chronic Kidney Disease Guidelines in a Managed Care Setting

about 22 years ago

Article

Genetic Testing and Pharmacogenomics: Issues for Determining the Impact to Healthcare Delivery and Costs

about 22 years ago

Article

Plan-Sponsor Savings and Member Experience With Point-of-Service Prescription Step Therapy

about 22 years ago

Article

Medical Management of Osteoporosis

about 22 years ago

Article

Prescribing Proton Pump Inhibitors for Initial Treatment of Acid-related Gastrointestinal Diseases in a Managed Care Population

about 22 years ago

Article

Using Guidelines to Improve Care of Patients With Chronic Kidney Disease

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Cost Impacts of Illness on Families and Society

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

Senate Unveils Sweeping Bill to Reform 340B Drug Program

Gene Therapy for Wet AMD Near an Inflection Point: Arshad Khanani, MD

Lipoprotein(a): An FAQ on Awareness, Risk, and Screening Gaps

Brexpiprazole and Dextromethorphan-Bupropion: Mechanisms of Action and Key Clinical Trial Data for Approved Alzheimer's Disease Agitation Therapies

JAK Inhibitor Hesitancy and Step Therapy in Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD